1. Home
  2. HALO vs OLED Comparison

HALO vs OLED Comparison

Compare HALO & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • OLED
  • Stock Information
  • Founded
  • HALO 1998
  • OLED 1985
  • Country
  • HALO United States
  • OLED United States
  • Employees
  • HALO N/A
  • OLED N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • OLED Semiconductors
  • Sector
  • HALO Health Care
  • OLED Technology
  • Exchange
  • HALO Nasdaq
  • OLED Nasdaq
  • Market Cap
  • HALO 7.4B
  • OLED 7.2B
  • IPO Year
  • HALO N/A
  • OLED 1992
  • Fundamental
  • Price
  • HALO $52.02
  • OLED $155.51
  • Analyst Decision
  • HALO Buy
  • OLED Strong Buy
  • Analyst Count
  • HALO 9
  • OLED 7
  • Target Price
  • HALO $63.56
  • OLED $190.43
  • AVG Volume (30 Days)
  • HALO 3.1M
  • OLED 710.9K
  • Earning Date
  • HALO 05-06-2025
  • OLED 05-01-2025
  • Dividend Yield
  • HALO N/A
  • OLED 1.15%
  • EPS Growth
  • HALO 55.40
  • OLED 4.58
  • EPS
  • HALO 3.76
  • OLED 4.81
  • Revenue
  • HALO $1,084,306,000.00
  • OLED $648,702,000.00
  • Revenue This Year
  • HALO $24.79
  • OLED $5.75
  • Revenue Next Year
  • HALO $22.65
  • OLED $10.76
  • P/E Ratio
  • HALO $13.83
  • OLED $31.83
  • Revenue Growth
  • HALO 25.64
  • OLED 6.13
  • 52 Week Low
  • HALO $41.28
  • OLED $103.70
  • 52 Week High
  • HALO $70.51
  • OLED $237.00
  • Technical
  • Relative Strength Index (RSI)
  • HALO 39.78
  • OLED 68.34
  • Support Level
  • HALO $47.50
  • OLED $139.13
  • Resistance Level
  • HALO $69.94
  • OLED $157.57
  • Average True Range (ATR)
  • HALO 3.52
  • OLED 5.41
  • MACD
  • HALO -1.49
  • OLED 2.57
  • Stochastic Oscillator
  • HALO 19.64
  • OLED 94.44

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: